| Document |
Document Title |
|
WO/2008/098503A1 |
A microbe composition comprising three viable and beneficial bacteria: Bifidobacterium longum, Lactobacillus acidophilus and Streptococcus faecalis. The invention further provides a method of preparing the composition with the addition o...
|
|
WO/2008/098254A2 |
The invention relates to processes that efficiently convert carbon-containing materials, such as biomass, into products in such a manner that the energy, carbon, and mass content of the materials are efficiently transferred into such pro...
|
|
WO/2008/094599A2 |
The invention provides a novel truncated mutated T4 RNA ligase 2. In addition, methods are provided for ligating pre-adenlylated donor molecules to the 3' hydroxyl group of RNA in the absence of ATP using the ligase.
|
|
WO/2008/090383A1 |
The present invention relates to methods of preparing bacterial growth inducers, and in particular to novel bacterial growth inducers/resuscitators prepared by such methods. The invention extends to various applications of such growth in...
|
|
WO/2008/087410A1 |
The present invention relates to the production of secondary metabolites from microorganisms. In particular, there are provided methods for inducing the rapid production of such compounds from a variety of microorganisms.
|
|
WO/2008/086750A1 |
Provided are the mixed fermentation method of callicarpa dichotoma (Lour.) K. Koch and edible fungus like auricularia auricula or cordyceps Militaris (l. exfr) link, and prepared products via said method, wherein the method comprises ste...
|
|
WO/2008/081082A1 |
A method and an apparatus enabling the simultaneous cultivation and product formation in both aerobic and anaerobic conditions of microbes or other production organisms in the same bioreactor. The used microbes may be facultatively anaer...
|
|
WO/2008/077229A1 |
The present invention relates to growth inhibition of microorganisms by lactic acid bacteria The present invention also relates the reduction and/or treatment of food-borne pathogen infections and/or nosocomial infections The present inv...
|
|
WO/2008/076738A2 |
The invention relates to a process of detoxifying pre-treated lignocellulose-containing material by subjecting pre-treated material to a detoxifying compound capable of binding 1) pre-treated lignocellulose degradation products and/or 2)...
|
|
WO/2008/076747A2 |
The invention relates to a process of fermenting plant material into a fermentation product using a fermenting organism, wherein one or more phytohormones are present during fermentation.
|
|
WO/2008/068602A2 |
The present invention provides method to produce fungi biomass from mycelia comprising inoculating differentiated cells or mycelia into a culture medium which contains at least NaNO3, KH2PO4, MgSO4, KCl, and a source of carbon. This meth...
|
|
WO/2008/065749A1 |
It is intended to provide a natural biodegradable material which has both properties of biodegradability and mechanical strength; a biodegradable film or container produced from the natural biodegradable material; a binder for producing ...
|
|
WO2008016709A9 |
A method and system for selectively fluorinating organic molecules on a target site wherein the target site is activated and then fluorinated are shown together with a method and system for identifying a molecule having a biological acti...
|
|
WO/2008/061187A1 |
Disclosed herein are preservative compositions comprising 1,3- propanediol, wherein the lf3-propanediol in said composition has a bio-based carbon content of about 1% to 100%. In addition, it is preferred that the 1,3-propanediof be biol...
|
|
WO/2008/052468A1 |
Lactobacillus rhamnosus strain SLR0406, which can exist for 30-60 days at 37 °C. A pharmaceutical composition comprising Lactobacillus rhamnosus strain SLR0406. The Lactobacillus rhamnosus strain SLR0406 CCTCC-M206023 according to the p...
|
|
WO/2008/048017A1 |
Disclosed herein are mutant strains, KCCM- 10784P and KCCM- 10785P, which are obtained through gene manipulation of Corynebacterium glutamicum KFCC-11074, and a process of producing L-glutamic acid using the mutant strains. The mutant st...
|
|
WO/2008/046855A1 |
The present invention describes an isolated polypeptide which has glucanotransferase activity, selected from the group consisting of: a) a polypeptide which has an amino acid sequence which has at least 40% amino acid sequence identity w...
|
|
WO/2008/037718A1 |
The present invention relates to a micro-organism belonging to the genius Gordonia able to produce and release extracellularly surface active compounds.
|
|
WO/2008/030854A2 |
The present application describes system and methods for maximizing efficiency and energy recovery from resource processing.
|
|
WO/2008/024129A2 |
Methods are provided for constructing a synthetic genome, comprising generating and assembling nucleic acid cassettes comprising portions of the genome, wherein at least one of the nucleic acid cassettes is constructed from nucleic acid ...
|
|
WO/2008/019941A1 |
The present invention relates to a method for the separation of enzymes and the concentration of biomass from a fermentation broth by means of dynamic cross flow filtration using rotating, ceramic overlapping membranes(2, 2').
|
|
WO/2008/011763A1 |
A high quality long chain dicarboxylic acid polyanhydride curing agent product is prepared by an biological process using alkane or fatty acid as starting raw material. The dicarboxylic acid polyanhydride curing agent can be used in curi...
|
|
WO/2008/011234A2 |
The invention provides a recombinant Escherichia coli host cell for producing an Escherichia coli L-asparaginase II enzyme. The host cell includes an Escherichia coli chromosome and at least one copy of a recombinant extrachromosomal vec...
|
|
WO/2008/010005A1 |
A method for on-line optimization of fed-batch fermentation unit containing bacteria and nutrients is disclosed. Parameters of the fermenter model used in optimization calculations are estimated periodically to reduce the mismatch betwee...
|
|
WO/2008/006832A1 |
The present invention relates to a method of targeting a protein of interest to an intracellular hydrophobic inclusion body of a bacterial cell by means of a fusion protein comprising a hydrophobic targeting peptide operatively linked wi...
|
|
WO/2008/005926A2 |
A system and related methods generate biomass in the presence of a fluid, primarily using natural light. The system in one embodiment includes a bioreactor vessel for receiving the fluid and biomass. The vessel includes a drain for drain...
|
|
WO/2008/004900A1 |
Eicosapentaenoic acid (EPA) compositions and EPA-rich polar lipids for prophylactic or therapeutic applications are described. Production from certain cultured micro-organisms (like Nitzschia laevis) promotes synthesis of EPA, including ...
|
|
WO/2008/000416A1 |
The present invention relates to microorganisms genetically engineered to reduce carbon source diversion throughout the bioconversion of a carbon source, such as e.g. sorbitol, into biomass. Processes for generating such microorganisms a...
|
|
WO/2008/000415A1 |
The present invention relates to microorganisms genetically engineered to reduce carbon source diversion throughout the bioconversion of a carbon source, such as e.g. sorbitol, into biomass. Processes for generating such microorganisms a...
|
|
WO/2008/002230A1 |
Product and products obtained using metabolically engineered bacteria or cell and lactose or other glycoside as initial acceptor for production of tri- and/or higher oligosaccharide glycosides.
|
|
WO/2007/144441A1 |
The present invention relates to a method for obtaining energy-generating compounds by means of electromagnetic energy produced by solar or artificial light, based on the use of phytoplankton cultivation.
|
|
WO/2007/140617A1 |
The invention is the production of magnetosome-like structures in cells. The invention provides in vitro and in viv o diagnostic and therapeutic methods using eukaryotic cells expressing magnetosome-like structures that act as contrast a...
|
|
WO/2007/143653A2 |
A method of facilitating the low cost, environmentally friendly generation of power or fuel using processing that produces an exhaust gas stream laden with carbon dioxide. In one aspect, the method involves using at least the carbon diox...
|
|
WO/2007/120198A2 |
In accordance with the subject invention, osmoprotectants, such as betaine, may be used to increase the productivity and titer of anaerobic and aerobic fermentation with E. coli. and other microbes. Betaine serves as a protective osmolyt...
|
|
WO/2007/107000A1 |
A process and method for the production of endophytes as plant inoculant products, specifically Clonostachys rosea strain 88- 710, for the promotion of plant vigor, health, growth and yield are disclosed. The endophyte, Clonostachys rose...
|
|
WO/2007/106041A1 |
This invention relates to the discovery of two novel actinomycete strains and the production of antitumour anthracycline polyketide antibiotic compounds.
|
|
WO/2007/101049A2 |
In one aspect, the invention relates to a method of converting byproducts of a fermentation process into oxygen and biomass. Related methods, systems, and other aspects are also described.
|
|
WO/2007/096855A2 |
The present invention relates to Angiotensin-I-converting enzyme inhibitors and to methods of producing such inhibitors comprising culturing a Lactobacillus strain in the presence of milk proteins. Strains useful in the production of the...
|
|
WO/2007/095787A1 |
A liquid fuel production method from biomass including biomass pretreatment process employing physical field and catalyst under normal temperature and pressure, the reaction conditions are mild and the operation is convenient which will ...
|
|
WO/2007/092582A2 |
The present invention relates to the field of bacteriology. In particular, the present invention provides compositions (e.g., a lantibiotic-based spore decontaminant (e.g., comprising nisin)) and methods of neutralizing (e.g., killing or...
|
|
WO/2007/085142A1 |
A method of manufacturing animal fermented concentrated feed is provided. The components and weight percentage in the feed are as follows: bean draff 30-50%, peanut draff 5-20%, corn protein powder 20-40%, calcium bicarbonate 5-10%, sodi...
|
|
WO/2007/084738A2 |
A process for the large-scale chemoenzymatic production of (6S)-5-methyl-5,6,7,8-tetrahydrofolic acid, also known as (6S)-5-methylTHFA, the process comprising the steps of: (1) reducing folic acid (FA) so as to yield dihydrofolic acid (D...
|
|
WO/2007/082032A2 |
An isolated microbial consortium is described that includes a first microbial consortium having Thermacetogenium phaeum to metabolize a complex hydrocarbon substrate into metabolic products comprising an acetate compound. The consortium ...
|
|
WO/2007/076633A1 |
A food for enhancing human body’s cell function prepared by utilizing microorganism metabolization, comprises proteins,amino acids,nucleic acids,nicotinic acids,multi- vitamins and microelements; the food is made by three steps; 1) pre...
|
|
WO/2007/073235A1 |
The invention relates to the food industry and to bioengineering, in particular to a method for producing from mushrooms a biologically active product exhibiting a hepatoprotective action. The inventive method for producing an biological...
|
|
WO/2007/071399A2 |
The present invention relates to methods for producing polypeptides or nucleic acids, in particular antisense RNA and hairpin RNA in filamentous fungi. The present invention also relates to isolated Penicillium promoter sequences and to ...
|
|
WO/2007/071072A1 |
The present invention relates to a novel perfusion bioreactor allowing continuous medium feed and extraction of metabolites or other desired products from cells. The invention is useful for plant cell cultures but may also be used for ma...
|
|
WO2007051315B1 |
The present invention relates to methods and processes for controlling fermentation. Two proportional feedback control loops are implemented in a cascade. One control loop is used to maintain the pH by adjusting the dissolved oxygen-stat...
|
|
WO/2007/063691A1 |
The invention is directed to a bacteriolytic agent characterized by containing a cationic surfactant (A) whose counter anion is an acid with a pKa value (25°C) of 0 to 10. The counter ion is preferably a carboxylate anion. The cationic ...
|
|
WO/2007/061102A1 |
In order to provide a method for culturing an immunostimulating compound-containing organism which has been consumed by humans at a low cost without the necessity of using an animal-derived component, by using a culture liquid containing...
|
